| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/14/2007 | EP1560828B9 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 02/14/2007 | EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 02/14/2007 | EP1532121B1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
| 02/14/2007 | EP1507514B1 Controlled release compositions of estradiol metabolites |
| 02/14/2007 | EP1506234B1 Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant |
| 02/14/2007 | EP1395554B1 Substituted carbazoles as inhibitors of spla2 |
| 02/14/2007 | EP1370552B1 Rho-kinase inhibitors |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1343876B1 Modulators of activity of g-protein-coupled receptor kinases |
| 02/14/2007 | EP1343757B1 Indole derivatives |
| 02/14/2007 | EP1341790B1 Sulfonamido ether substituted imidazoquinolines |
| 02/14/2007 | EP1296961B1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 02/14/2007 | EP1278763B1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 02/14/2007 | EP1128813B1 An inhalation system |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | EP1124959B1 Cell surface molecule-induced macrophage activation |
| 02/14/2007 | EP1063982B1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
| 02/14/2007 | EP1017676B1 Method for the synthesis of quinoline derivatives |
| 02/14/2007 | EP1009413B1 Use of immunostimulatory oligonucleotides for preventing or treating asthma |
| 02/14/2007 | CN1914205A Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
| 02/14/2007 | CN1914196A 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratiory syncytial virus replication |
| 02/14/2007 | CN1913906A Lactic acid producing bacteria and lung function |
| 02/14/2007 | CN1913895A Novel M3 muscarinic acetylcholine receptor antagonists |
| 02/14/2007 | CN1913883A Combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD |
| 02/14/2007 | CN1913882A Treatment of rhinitis with anticholinergics alone or in combination with antihistamines, phosphodiesterase 4 inhibitors, or corticosteroids |
| 02/14/2007 | CN1913873A Medical product containing tiotropium incorporated in a waterproof container |
| 02/14/2007 | CN1913872A Pre-metered dry powder inhaler for moisture-sensitive medicaments |
| 02/14/2007 | CN1911963A SARS neutralization antibody and application |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/14/2007 | CN1911445A Grippe primary generation susliks kidney cell multivalent raccine and its preparation method |
| 02/14/2007 | CN1911439A Orally administered peptides to ameliorate atherosclerosis |
| 02/14/2007 | CN1911438A 血管新生诱导剂 Angiogenic inducer |
| 02/14/2007 | CN1911418A Aerosol agent contg. traditional Chinese medicine for treating rhinitis, and its prepn. method |
| 02/14/2007 | CN1911408A Decoction for treating lung and stomach excessive heat type acute tonsillitis, and its prepn. method |
| 02/14/2007 | CN1911364A Decoction for treating chronic tonsillitis, and its prepn. method |
| 02/14/2007 | CN1911309A Drug applied at acupoint for treating acute tonsillitis and its prepn. method |
| 02/14/2007 | CN1911302A Medicine composition for treating viral inflammation, and its prepn. method |
| 02/14/2007 | CN1911287A Drug applied at acupoint for treating tonsillitis, and its prepn. method |
| 02/14/2007 | CN1911279A Acupuncture point plaster for preventing and treating bronchitic asthma and its prepn. method |
| 02/14/2007 | CN1911278A Soft capsule contg. Bupleurum and Radix scutellariae, prepn. method and use thereof |
| 02/14/2007 | CN1911269A Soft capsule of Rabdosia rubescens, and its prepn. method |
| 02/14/2007 | CN1911232A Theophylline chitin micro-balls slow-release prepn., and its prepn. method |
| 02/14/2007 | CN1911228A Nasal cavity gel contg. levomisole, and its new use |
| 02/14/2007 | CN1911227A Novel prepn. of levomisole, and its new use |
| 02/14/2007 | CN1911226A Novel prepn. of thiabendazole, and its new use |
| 02/14/2007 | CN1911224A Nasal cavity gel contg. membendazole, and its new use |
| 02/14/2007 | CN1911223A Prepn. of mebendazole for treating adenoid hypertrophy |
| 02/14/2007 | CN1300173C Human antibodies that bind huma TNF 'alpha' |
| 02/14/2007 | CN1300172C Immunoglobulin antibody against SARS-CoV and its preparing method |
| 02/14/2007 | CN1300155C Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase |
| 02/14/2007 | CN1300114C Phenylpyridine carbonyl piperazine derivative |
| 02/14/2007 | CN1300113C Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2007 | CN1299770C Multifunctional liquid for clean therapy of nasal cavity and sinuses |
| 02/14/2007 | CN1299720C Medicine composition for curing cold |
| 02/14/2007 | CN1299707C Yinhuang oral liquor and its producing process |
| 02/14/2007 | CN1299683C Celecoxib compositions |
| 02/14/2007 | CN1299676C Anti-anoxia medicinal composition |
| 02/14/2007 | CN1299673C Ambroxol hydrochloride drop pills and its preparation method |
| 02/13/2007 | US7176345 Rodent model comprising genes coding hypoxia inducible factor (HIF) for detection of hypoxic tissue |
| 02/13/2007 | US7176241 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase |
| 02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
| 02/13/2007 | US7176219 Salts of quinuclidine derivative |
| 02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
| 02/13/2007 | US7175987 administering to mammals mixtures of plant extracts from ginger, green tea, turmeric, horseradish and carriers |
| 02/13/2007 | US7175850 Formulation for topical non-invasive application in vivo |
| 02/13/2007 | US7175849 Polypeptide for use in the treatment of viral disorders |
| 02/13/2007 | CA2295119C Use of a specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing |
| 02/08/2007 | WO2007015668A1 New salt iii |
| 02/08/2007 | WO2007015667A1 New salt ii |
| 02/08/2007 | WO2007015666A1 New salt i |
| 02/08/2007 | WO2007015664A1 Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases. |
| 02/08/2007 | WO2007014838A1 Dihydropteridinones in the treatment of respiratory diseases |
| 02/08/2007 | WO2007014586A1 Use of megestrol acetate for the treatment of obstructive pulmonary diseases |
| 02/08/2007 | WO2006091841A3 Compositions and their uses directed to il-4r alpha |
| 02/08/2007 | WO2006063837A3 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| 02/08/2007 | US20070032525 e.g. (1H-benzoimidazol-2-yl)-[1-(3,4-dichloro-benzyl)-piperidin-4-ylmethyl]-amine; chemokine (C-C motif) receptor antagonist; antiallergen; asthma and allergic rhinitis, atopic dermatitis, urticaria, contact dermatitis, alleriric coniunctivitis, inflammatory bowel disease, AIDS, eosinqphilia |
| 02/08/2007 | US20070032411 Protein kinase signalling |
| 02/08/2007 | US20070031887 Aqueous-based pharmaceutical composition |
| 02/08/2007 | US20070031510 Pharmaceutical combination preparation containing glycyrrhizine, zinc, and a compound comprising a thiol group or a group that is metabolized thereto |
| 02/08/2007 | US20070031489 administering sub-analgesic dosage of a mu -opioid agonist selected from morphine, fentanyl, sufentanil, alfentanil, oxymorphone and hydromorphone, or salt, and a sub-analgesic dosage of oxycodone, a kappa 2-opioid agonist to prevent sleep apnea while treating pain |
| 02/08/2007 | US20070031377 Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity |
| 02/08/2007 | US20070031375 IL-16 antagonist peptides and DNA encoding the peptides |
| 02/08/2007 | US20070031344 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 02/08/2007 | DE102005036216A1 Use of quinazoline derivatives e.g. 4-((3-chloro-4-fluoro-phenyl)amin o)-6-(1-methanesulfonyl-piperidin-4-yloxy)-7-methoxy-quinazoline, which are tyrosine kinase inhibitors, to prevent or treat symptoms of e.g. chronic rhinosinusitis |
| 02/08/2007 | DE102005035575A1 New heteroaryl derivatives are phosphodiesterase-4 enzyme inhibitors useful for the treatment of e.g. respiratory or gastrointestinal complaints or diseases, depression, Alzheimer's disease and Parkinson's disease |
| 02/08/2007 | CA2617589A1 Dihydropteridinones in the treatment of respiratory diseases |
| 02/08/2007 | CA2617406A1 New salt iii |
| 02/08/2007 | CA2617404A1 New salt ii |
| 02/08/2007 | CA2617403A1 New salt i |
| 02/08/2007 | CA2617127A1 Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases. |
| 02/07/2007 | EP1749840A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 02/07/2007 | EP1749531A1 Use of megestrol acetate for the treatment of obstructive pulmonary diseases |
| 02/07/2007 | EP1749524A2 Inflammation-inhibiting compounds |
| 02/07/2007 | EP1749012A1 Muscarinic acetylcholine receptor antagonists |
| 02/07/2007 | EP1542753B1 Pharmaceutical compositions |
| 02/07/2007 | EP1536798B1 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| 02/07/2007 | EP1501504B1 1-substituted imidazole derivatives as nos inhibitors |
| 02/07/2007 | EP1261336B1 Il-8 receptor antagonists |